(Q47647383)

4 February 2018

title

Antipsychotic agents: a clinical update (English)

1 reference

4 February 2018

author name string

J L Black

series ordinal

1

1 reference

4 February 2018

E Richelson

series ordinal

2

1 reference

4 February 2018

J W Richardson

series ordinal

3

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 November 1985

1 reference

4 February 2018

published in

Mayo Clin Proc

1 reference

4 February 2018

volume

60

1 reference

4 February 2018

issue

11

1 reference

4 February 2018

page(s)

777-789

1 reference

4 February 2018

Multiple receptors for dopamine

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Antidepressants are weak competitive antagonists of histamine H2 receptors in dissociated brain tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Predicting response to phenothiazines: the right drug for the right patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Is loxapine more effective than chlorpromazine in paranoid schizophrenia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Negative v positive schizophrenia. Definition and validation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Prediction of response to phenothiazines in schizophrenia. A crossvalidation study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Prediction of Improvement in Schizophrenia Under Four Phenothiazines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

7 January 2021

Delusions of parasitosis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Successful suicides with thioridazine and mesoridazine: a result of probable cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Neuroleptic-induced prolactin level elevation and breast cancer: an emerging clinical issue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Epilepsy: psychiatric aspects and use of psychotropics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

The pharmacologic treatment of schizophrenia: a progress report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

The discontinuance of maintenance neuroleptic therapy in chronic schizophrenic patients: drug and social consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Blood levels of haloperidol and thioridazine during maintenance neuroleptic treatment of schizophrenic outpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

High doses of diazepam improve neuroleptic-resistant chronic schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Lithium Treatment in Schizophrenia and Schizo-Affective Disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Serum levels of anticholinergic drugs and impaired recent memory in chronic schizophrenic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Transient cognitive disorders (delirium, acute confusional states) in the elderly.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Treatment of the acute alcohol withdrawal state: a comparison of four drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Treatment of Tourette's syndrome with haloperidol, review of 34 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Treatment of vascular hemiballism and hemichorea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Rheumatic chorea controlled with haloperidol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Haloperidol treatment of chorea associated with systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

The Medical Treatment of Spasmodic Torticollis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Meige disease: Striatal dopaminergic preponderance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Pharmacology of blepharospasm-oromandibular dystonia syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

The pharmacology of tardive dyskinesias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Peripheral Diabetic Neuropathy Treated With Amitriptyline and Fluphenazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Treatment of intractable hiccups with valproic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Intravenous diazepam in drug-induced dystonic reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Amantadine in the Management of Extrapyramidal Side Effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

A Controlled Trial of Amantadine in Drug-Induced Extrapyramidal Disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Propranolol in the treatment of neuroleptic-induced akathisia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Neuroleptic malignant syndrome: response to dantrolene sodium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Treatment of neuroleptic malignant syndrome with dantrolene sodium: a case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Increased brain dopamine and dopamine receptors in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Tardive Dyskinesia in an Outpatient Population: Prevalence and Predisposing Factors*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Tardive dyskinesia: A two-year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Deanol in the treatment of tardive dyskinesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Physostigmine in choreiform movement disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Effects of dopamine agonists in tardive dyskinesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Tardive dyskinesia in depressed patients: successful therapy with antidepressants and lithium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Tetrabenazine and movement disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Tardive dystonia: Late-onset and persistent dystonia caused by antipsychotic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

AGRANULOCYTOSIS ASSOCIATED WITH THIORIDAZINE ADMINISTRATION.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Allergic reactions to tranquilizing drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

COMPLICATIONS FROM PSYCHOTHERAPEUTIC DRUGS--1964.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Clinical-ultrastructural study of thioridazine retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Antipsychotic drug use and birth defects: An epidemiologic reassessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Lithium Carbonate, Haloperidol, and Irreversible Brain Damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

New data on lithium and haloperidol incompatibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Reduced steady-state plasma concentrations of chlorpromazine and indomethacin in patients receiving cimetidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Phenothiazine-induced phenytoin intoxication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Thioridazine-induced torsade de pointes. Successful therapy with isoproterenol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

Blockade of Dopamine Receptors in the Renal Vasculature by Isomers of Flupenthixol and Sulpiride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960421-2

10.1016/S0025-6196(12)60421-2

7 January 2021

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018